Modendo Inc.

Boulder, CO

UEI
HRW3QRF7LP38
CAGE
91M70
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1898 S Flatiron Ct #115, Boulder, CO 80301, USA
Website
modendo-inc.com
Founded
2021
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract subawards

Prime contractor Prime award Amount Awarded
Battelle Memorial Institute MICROELECTRONICS EMBEDDED SYSTEM AND ASSURANCE II Imagining prototype FA865023C1000 $185,000

Grant awards

Similar vendors

About the company

Modendo Inc. is a for-profit corporate entity registered in SAM.gov, specializing in advanced biomedical engineering and optical imaging technologies for neuroscience research. The company focuses on developing innovative, minimally invasive imaging technologies that enable high-resolution scientific exploration of complex biological systems, particularly in neural research. Their primary technological focus appears to be creating ultrathin endomicroscopes with exceptional capabilities for deep brain imaging and neurological research, utilizing cutting-edge approaches in fiber optics, wavefront shaping, and machine learning signal processing techniques.

Through federal grant awards, Modendo Inc. has consistently received funding from civilian scientific agencies, primarily the National Science Foundation (NSF) and the National Institute of Neurological Disorders and Stroke, to develop progressive generations of ultrathin endomicroscope prototypes. Their grant-funded projects, including Small Business Innovation Research (SBIR) Phase I and Phase II awards, aim to create imaging instruments with unprecedented capabilities, such as probes with cross-sections approximately 10 times smaller than existing endoscopes. These instruments are designed to enable high-resolution, 3D optical imaging and photo-stimulation of neurons with minimal tissue damage, potentially advancing research into neurological conditions like Alzheimer's disease. The grants, totaling approximately $1.25 million, support the development of multi-probe systems capable of simultaneously imaging and stimulating multiple brain regions, with potential long-term applications in medical diagnostics and treatment development.

Quick answers

Is Modendo Inc. registered in SAM.gov?

Yes. Modendo Inc.'s SAM.gov registration is active through June 5, 2027.

What is Modendo Inc.'s most recent federal award?

Modendo Inc.'s most recent federal grant award is Sbir phase II: ultrathin endomicroscope (2415645), from National Science Foundation, on August 15, 2024.

On GovTribe

See Modendo Inc.'s full federal record

  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors